|
|
|
Insider
Information: |
Goldberg Mark Alan |
Relationship: |
|
City: |
Lexington |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
79,501 |
|
Indirect Shares
|
11,497 |
|
|
Direct
Value |
$1,666,079 |
|
|
Indirect Value
|
$3,246 |
|
|
Total
Shares |
90,998 |
|
|
Total
Value |
$1,669,325 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-26.6%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
|
0 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
|
2014-09-19 |
562 |
2013-01-02 |
0 |
Premium* |
|
Glycomimetics Inc |
GLYC |
|
2024-03-29 |
24,828 |
2024-03-29 |
11,497 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
2021-01-04 |
38,099 |
2018-12-19 |
0 |
Premium* |
|
Blueprint Medicines Corp |
BPMC |
|
2023-06-21 |
16,012 |
2020-06-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GEVA |
Synageva BioPharma Corp |
SVP,Medical&Regulatory Affairs |
|
2013-12-02 |
4 |
OE |
$8.73 |
$61,110 |
D/D |
7,000 |
7,267 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
EVP, Medical & Reg. Strategy |
|
2014-06-11 |
4 |
OE |
$0.95 |
$165,513 |
D/D |
21,597 |
22,056 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
EVP, Medical & Reg. Strategy |
|
2014-09-16 |
4 |
OE |
$8.73 |
$81,879 |
D/D |
9,379 |
9,941 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
EVP, Medical & Reg. Strategy |
|
2014-09-17 |
4 |
OE |
$8.73 |
$36,666 |
D/D |
4,200 |
4,762 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
EVP, Medical & Reg. Strategy |
|
2014-09-19 |
4 |
OE |
$8.73 |
$6,897 |
D/D |
790 |
1,352 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
Director |
|
2020-06-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,312 |
1,312 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
Director |
|
2020-10-07 |
4 |
OE |
$19.53 |
$106,517 |
D/D |
5,454 |
9,016 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
Director |
|
2020-10-19 |
4 |
OE |
$19.53 |
$106,536 |
D/D |
5,455 |
9,017 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
Director |
|
2020-12-01 |
4 |
OE |
$28.15 |
$153,530 |
D/D |
5,454 |
9,016 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
Director |
|
2020-12-11 |
4 |
OE |
$28.15 |
$153,558 |
D/D |
5,455 |
9,017 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
Director |
|
2020-12-18 |
4 |
OE |
$28.15 |
$153,530 |
D/D |
5,454 |
9,016 |
0 |
- |
|
BPMC |
Blueprint Medicines Corp |
Director |
|
2020-12-24 |
4 |
OE |
$28.15 |
$153,558 |
D/D |
5,455 |
9,017 |
0 |
- |
|
IMGN |
Immunogen Inc |
|
|
2023-10-30 |
4 |
OE |
$14.70 |
$147,000 |
D/D |
10,000 |
70,151 |
0 |
- |
|
IMGN |
Immunogen Inc |
|
|
2023-10-30 |
4 |
OE |
$15.08 |
$150,800 |
D/D |
10,000 |
60,151 |
0 |
- |
|
64 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|